Clinical Trial

Clinical Study of Endocardial Myocardial Biopsy

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT05718128
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Myocarditis, Cardiomyopathies, Heart Failure, Cardiac Tumor, Endocardiomyocardial Biopsy
Enrollment 100 participants
Start Date 2021-06-01
Primary Completion 2031-06-01 (estimated)
Study Completion 2031-06-01 (estimated)
Updated on ClinicalTrials.gov 2023-03-28